Pro Research: Wall Street dives into Amgen’s diverse biopharma strategies By Investing.com
[ad_1] Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy with ProPicks,...
Hansa Biopharma reports robust Q4 with SEK 50m revenue By Investing.com
[ad_1] © Reuters. LUND, Sweden – Hansa Biopharma, a leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced a business update for the fourth...